CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer

Cancer stem cells (CSCs) are responsible for tumor progression, recurrence, and drug resistance. To identify genetic vulnerabilities of colon cancer, we performed targeted CRISPR dropout screens comprising 657 Drugbank targets and 317 epigenetic regulators on two patient-derived colon CSC-enriched s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shanshan, Soares, Fraser, Wang, Shiyan, Wong, Chi Chun, Chen, Huarong, Yang, Zhenjie, Liu, Weixin, Go, Minnie Y. Y., Ahmed, Musaddeque, Zeng, Yong, O’Brien, Catherine Adell, Sung, Joseph J. Y., He, Housheng Hansen, Yu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639446/
https://www.ncbi.nlm.nih.gov/pubmed/34621019
http://dx.doi.org/10.1038/s41388-021-01882-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639446/
https://www.ncbi.nlm.nih.gov/pubmed/34621019
http://dx.doi.org/10.1038/s41388-021-01882-7

Ejemplares similares